Dinkelborg, K. Et Al. 2023. Quality-of-life scores improve after 96 weeks of PEG-IFNa-2a treatment of hepatitis D: An analysis of the HIDIT-II trial. Liver International , vol.43, no.8 , 1663-1676.

Dinkelborg, K., Kahlhöfer, J., Dörge, P., Yurdaydin, C., Hardtke, S., Caruntu, F. A., ... Curescu, M. G.(2023). Quality-of-life scores improve after 96 weeks of PEG-IFNa-2a treatment of hepatitis D: An analysis of the HIDIT-II trial. Liver International , vol.43, no.8, 1663-1676.

Dinkelborg, Katja Et Al. "Quality-of-life scores improve after 96 weeks of PEG-IFNa-2a treatment of hepatitis D: An analysis of the HIDIT-II trial," Liver International , vol.43, no.8, 1663-1676, 2023

Dinkelborg, Katja Et Al. "Quality-of-life scores improve after 96 weeks of PEG-IFNa-2a treatment of hepatitis D: An analysis of the HIDIT-II trial." Liver International , vol.43, no.8, pp.1663-1676, 2023

Dinkelborg, K. Et Al. (2023) . "Quality-of-life scores improve after 96 weeks of PEG-IFNa-2a treatment of hepatitis D: An analysis of the HIDIT-II trial." Liver International , vol.43, no.8, pp.1663-1676.

@article{article, author={Katja Dinkelborg Et Al. }, title={Quality-of-life scores improve after 96 weeks of PEG-IFNa-2a treatment of hepatitis D: An analysis of the HIDIT-II trial}, journal={Liver International}, year=2023, pages={1663-1676} }